|  | 
  No comments have been submitted
    | June 17, 2009: Drs. Harrington and Gibson discuss the BARI 2D trial, factor 10a inhibitors, and the need for more sensitive bleeding me |  
    | In this edition of Inside Cardiology, Dr. Harrington and Dr.Gibson discuss the BARI 2D trial, factor 10a inhibitors, and the need for more sensitive bleeding measures.
 
 Present Research/Grant Funding
 
 Abbott; Angel Medical Corporation; Astra Zeneca; Atrium Medical Systems; Baxter; Bayer
 Corp. Cardica, Inc.; FibroGen, Inc.; Fold Rx; Genentech, Inc.; HeartScape Technologies;
 INO Therapeutics, Inc.; Johnson & Johnson Corporation; Lantheus Medical Imaging;
 NewCardio, Inc.; Portola Pharmaceuticals; Sanofi-Aventis; Schering Plough Corporation
 
 
 Speakers Bureau
 
 Daiichi Sankyo Company, Inc; Eli Lilly and Company; Glaxo SmithKline; Schering Plough
 Corporation; The Medicines Company
 
 
 Consultant
 
 Acusphere, Inc.; Angel Medical Systems; Archemix Corporation; Ascenta Therapeutics Atrium
 Medical Corporation; Bayer Corporation; Cardica Inc.; Heartscape Technologies, Inc.; ICON
 Medical Imaging; Jim Moran Heart and Vascular Research Institute; John & Johnson
 Corporation; Medicure, Inc.; Novartis Pharmaceutical Corporation; Portola Pharmaceuticals,
 Inc.; Sanofi-Aventis Pharmaceuticals; Schering Plough Corporation; St. Jude Medical; The
 Medicines Company
 
 
 Stock Ownership
 
 My wife owns stock in HealthMarx Inc.
 
 
 Royalties as a Contributor
 
 UpToDate in Cardiovascular Medicine; Pocket Medicine
 
 
 Past Research/Grant Funding/Past Speakers Bureau/Past Consulting
 
 ActivBiotics, Inc.; Acusphere, Inc.; Ascenta Therapeutics, Inc; Astra; Atrium Medical
 Corporation; Bard Corporation; Biogen IDEC; Boston Scientific Corporation; Bristol Meyers
 Squibb Company; British Biotech, plc.; CardioKinetix, Inc.; Ciba Geigy Corporation; COR
 Therapeutics; Corgentech, Inc.; DVI Guidant Corporation; Eli Lilly and Company; Genentech,
 Inc.; GlaxoSmithKline; INO Therapeutics, LLC; KAI Pharmaceuticals; Merck & Co., Inc.;
 Millennium Pharmaceuticals; Momenta Pharmaceuticals; NIH; Novartis Corporation; Nuvelo;
 PDL Pharmaceuticals; Percusurge, Inc.; Pfizer; Point Biomedical Corporation; Portola
 Pharmaceuticals, Inc.; Sanofi-Aventis Corporation; Smith Kline Beecham; Sonus; St. Jude
 Medical; The Medicines Company; timi3 Systems, Inc.
 
 [ Download video ]
 |   |  
 |